Dass-167 | [work]

The DASS-167 has been shown to exhibit antiviral activity against a range of viruses, including HIV, HCV, and influenza. The compound works by targeting the viral replication process, specifically by inhibiting the activity of the viral RNA-dependent RNA polymerase (RdRp) enzyme. This enzyme is essential for the replication of viral RNA, and its inhibition prevents the production of new viral particles.

By continuing to refine and expand our understanding of the DASS-167, researchers and clinicians can work together to improve the assessment and treatment of mental health disorders. DASS-167